SCHEMBL18501083

SCHEMBL18501083

O=P(O)(O)OCCNC1CCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 2/20 0.40
ERAP2 Q6P179 2/20 0.40
S1PR4 O95977 1/20 0.40
S1PR1 P21453 1/20 0.40
S1PR3 Q99500 1/20 0.40
S1PR5 Q9H228 1/20 0.40
MMP2 P08253 3/20 0.38
MMP8 P22894 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
KDM4E B2RXH2 6/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
CXCR4 P61073 1/20 0.36
ALDH1A1 P00352 5/20 0.35
TDP1 Q9NUW8 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
LPAR3 Q9UBY5 3/20 0.34
LPAR1 Q92633 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18501084 0.96 ANPEP (0.43) ANPEPERAP2S1PR4S1PR1S1PR3
SCHEMBL18501082 0.92 S1PR4 (0.37) ANPEPERAP2S1PR4S1PR1S1PR3
SCHEMBL18501121 0.76 CA12 (0.41) ANPEPERAP2MMP2MMP8KDM4E
SCHEMBL13451331 0.73
SCHEMBL18501123 0.71 SAT1 (0.38) ANPEPERAP2MMP2MMP8TDP1
SCHEMBL17859165 0.69 LPAR3 (0.44) LPAR3LPAR1LPAR2
SCHEMBL6026425 0.69 INPP5A (0.41) ANPEPERAP2S1PR4S1PR1S1PR3
SCHEMBL5482641 0.69 KDM4E (0.55) L3MBTL1KDM4ECYP1A2CYP2D6CYP2C19
SCHEMBL16754235 0.68 SMN1; SMN2 (0.43) L3MBTL1KDM4ECYP1A2CYP2D6CYP2C19
SCHEMBL13941965 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9567358-B2 Methods of treatment using N-(3-fluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide ASTRAZENECA AB (SE) 2017-02-14 US disclosed